Facilitated percutaneous intervention following combination therapy with reteplase and abciximab for acute myocardial infarction.
Weinstock
Barry S
BS
Bay Area Heart Center, 4805 49th St. North, St. Petersburg, FL 33709, USA. bweinstock@bahc.com
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002404:Catheterization; D017023:Coronary Angiography; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; C087896:reteplase; D010959:Tissue Plasminogen Activator; D000077284:Abciximab